全球造影剂市场：区域、范围和预测

造影剂的全球市场规模及预测

2024 年全球造影剂市值为 55.4 亿美元，预计到 2031 年将达到 68 亿美元，2024 年至 2031 年的复合年增长率为 2.59%。造影剂，也称为造影介质，是医学影像技术中用来增强身体内部结构可见度的物质。该市场服务于各种医疗保健机构，包括医院、诊断中心和门诊手术中心，并为各种影像方式提供解决方案，包括 X 光/CT、MRI 和超音波。

造影剂市场的未来将受到慢性病盛行率不断上升、影像技术的进步、微创手术需求不断增长以及全球医疗支出不断上升的影响。

全球造影剂市场动态

影响全球造影剂市场的关键市场动态

主要市场驱动因子

慢性病发生率不断上升：

全球慢性病（尤其是心血管疾病和癌症）的增加大大增加了对诊断影像的需求。这种趋势导致对造影剂的依赖性增加，而造影剂对于提高医学影像的可见性和准确性以及最终改善患者的治疗效果至关重要。

技术进步：

诊断影像技术的最新进展正在彻底改变诊断实​​践。开发安全性更高、影像能力更强的新型造影剂对市场发展起着关键作用。这些进步使得诊断更加准确，并有利于医疗保健环境中更好的治疗计划和患者管理。

老年人口不断增加：

日益增长的老年人口特别容易患上各种需要先进影像诊断的疾病。老年人通常需要更频繁的医疗评估，对可靠的诊断影像解决方案的需求增加，从而推动了对造影剂的需求。这一趋势凸显了为老年人制定量身定制的医疗保健策略的重要性。

增加医疗支出：

已开发国家和发展中国家医疗保健支出的增加为引进先进的影像技术和卓越的造影剂铺平了道路。这些财政支出将支持改进技术，使医疗专业人员能够提供准确的诊断和有效的治疗，最终有利于患者护理和治疗结果。

主要问题

副作用与过敏反应：

造影剂相关的潜在副作用和过敏反应，尤其是对肾功能不全患者的担忧，对市场成长构成了课题。儘管正在开发更安全的药物，但这些风险仍然是广泛使用的障碍，需要仔细的患者筛检和监测。

成本高：

造影剂的成本很高，特别是对于先进的影像方式而言，这可能会限制其在资源受限的医疗保健环境中的采用。虽然这些造影剂可以提高诊断的准确性，但其高昂的价格可能会让预算有限的小型诊所和医疗机构难以负担。

严格的监理要求：

围绕成像媒体产品的严格审批流程和规定可能会延迟市场进入并增加製造商的开发成本。这些措施虽然确保了产品的安全性和有效性，但也减缓了创新，并为试图在市场上竞争的中小企业设置了障碍。

缺乏熟练的放射科医师：

全球缺乏经过培训的放射科医生和技术人员来管理造影剂和解释清晰影像，这对市场扩张构成了重大课题。儘管正在努力增加培训项目，但缺乏专业知识仍然限制了各个地区对比技术的充分利用。

主要趋势：

器官特异性造影剂的开发：

开发用于特定器官和组织成像的专用造影剂的趋势日益增长，从而可以实现更有针对性和更有效的诊断。

增加微泡造影剂的使用：

微泡造影剂在超音波影像中的应用越来越广泛，特别是在心臟病学和放射学应用中，因为它们可以在不使用电离辐射的情况下提高影像品质。

转向病人友善配方：

为了最大限度地降低患者不适和副作用的风险，造影剂製造商正在努力开发造影剂，重点是提高安全性、降低渗透压和提高耐受性。

人工智慧整合：

人工智慧和机器学习越来越多地被纳入成像工作流程中，以改善影像品质、减少对比剂剂量并提高诊断准确性。

目录

第 1 章：全球造影剂市场简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章 全球造影剂市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

第 5 章全球造影剂市场（按类型）

• 概述
• 微泡造影剂
• 碘基造影剂
• 钆基造影剂
• 钡基造影剂

第6章 显影剂全球市场（依应用）

• 概述
• 放射科
• 介入性放射学
• 介入性心臟病学

第7章全球影像造影剂市场（依方式划分）

• 概述
• X 光/电脑断层扫瞄 (CT) 超音波
• 磁振造影（MRI）

第8章全球影像造影剂市场（依给药途径划分）

• 概述
• 口服
• 血管内
• 直肠
• 其他给药途径

第 9 章全球造影剂市场（依适应症划分）

• 概述
• 心血管疾病
• 癌症
• 消化系统疾病
• 其他

第 10 章 全球显影剂市场（按区域）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东

第 11 章全球造影剂市场的竞争格局

• 概述
• 各公司的市场排名
• 主要发展策略

第 12 章 公司简介

• GE Healthcare
• Guerbet LLC
• Bayer AG
• Bracco Diagnostics Inc.
• Lantheus Medical Imaging, Inc.
• Daiichi Sankyo Co. Ltd,
• Fuji Pharma Co., Ltd

第13章 附录

• 关联调查

Global Contrast Media Market Size and Forecast

The Global Contrast Media Market was valued at USD 5.54 Billion in 2024 and is projected to reach USD 6.8 Billion by 2031 growing at a CAGR of 2.59% from 2024 to 2031. Contrast media, also known as contrast agents, are substances used to enhance the visibility of internal body structures in medical imaging techniques. The market serves various healthcare settings, including hospitals, diagnostic centers and ambulatory surgical centers, offering solutions for different imaging modalities such as X-ray/CT, MRI and ultrasound.

The future of the contrast media market is shaped by increasing prevalence of chronic diseases, technological advancements in imaging techniques, growing demand for minimally invasive procedures and rising healthcare expenditure globally.

Global Contrast Media Market Dynamics

The key market dynamics that are shaping the global contrast media market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases:

The global rise in chronic diseases, notably cardiovascular disorders and cancer, is significantly increasing the demand for diagnostic imaging procedures. This trend leads to a greater reliance on contrast media, essential for enhancing the visibility and accuracy of medical imaging, ultimately improving patient outcomes.

Technological Advancements:

Recent innovations in imaging technologies are revolutionizing diagnostic practices. The development of novel contrast agents, which feature improved safety profiles and enhanced imaging capabilities, plays a crucial role in market growth. These advancements ensure more precise diagnostics, facilitating better treatment planning and patient management in healthcare settings.

Growing Geriatric Population:

The expanding elderly population is particularly vulnerable to various diseases that necessitate advanced diagnostic imaging. As older adults typically require more frequent medical assessments, the increasing need for reliable imaging solutions drives the demand for contrast media. This trend underscores the importance of tailored healthcare strategies for seniors.

Increasing Healthcare Expenditure:

Rising healthcare expenditures in both developed and developing nations are paving the way for the adoption of advanced imaging techniques and superior contrast agents. This financial commitment supports technological upgrades, ensuring healthcare providers can deliver accurate diagnoses and effective treatments, ultimately benefiting patient care and outcomes.

Key Challenges:

Side Effects and Allergic Reactions:

Concerns about potential side effects and allergic reactions related to contrast media, especially in patients with renal impairment, present challenges for market growth. While advancements are being made to develop safer agents, these risks still hinder broader adoption and necessitate careful patient screening and monitoring.

High Costs:

The significant costs associated with contrast agents, particularly for advanced imaging modalities, can limit their adoption in resource-constrained healthcare settings. Though these agents offer improved diagnostic accuracy, their high price tags may be prohibitive for smaller clinics and healthcare facilities with limited budgets.

Stringent Regulatory Requirements:

The rigorous approval processes and strict regulations surrounding contrast media products can delay market entry and increase development costs for manufacturers. While these measures ensure product safety and efficacy, they also slow down innovation and raise barriers for smaller companies trying to compete in the market.

Shortage of Skilled Radiologists:

The global shortage of trained radiologists and technicians capable of administering contrast media and interpreting enhanced images poses a significant challenge to market expansion. While efforts are being made to increase training programs, the lack of expertise continues to limit the full utilization of contrast media technologies in various regions.

Key Trends:

Development of Organ-Specific Contrast Agents:

There is a growing trend towards the development of contrast media specifically designed for imaging particular organs or tissue types, allowing for more targeted and efficient diagnostic procedures.

Increasing Use of Microbubble Contrast Agents:

The adoption of microbubble contrast agents for ultrasound imaging is rising, particularly in cardiology and radiology applications, due to their ability to enhance image quality without ionizing radiation.

Shift Towards Patient-Friendly Formulations:

Manufacturers are focusing on developing contrast media with improved safety profiles, reduced osmolality and better tolerability to minimize patient discomfort and risk of adverse reactions.

Integration of Artificial Intelligence:

AI and machine learning are increasingly being incorporated into contrast-enhanced imaging workflows to improve image quality, reduce contrast media dose and enhance diagnostic accuracy.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Contrast Media Market Regional Analysis

Here is a more detailed regional analysis of the global contrast media market:

North America:

According to Verified Market Research, North America is expected to dominate the Global contrast media market.

North America is expected to hold a significant share in the Global contrast media market due to its advanced healthcare infrastructure, high adoption rate of medical imaging technologies and presence of key market players.

The United States is a major contributor to market growth, driven by the high prevalence of chronic diseases and substantial healthcare spending.

The region's focus on early disease detection and preventive healthcare is driving the demand for diagnostic imaging procedures and, consequently, contrast media.

Canada's universal healthcare system and increasing investments in healthcare infrastructure are also contributing to the expansion of the contrast media market in the region.

Europe:

According to Verified Market Research, Europe is the fastest growing region in Global contrast media market.

Europe represents a substantial market for contrast media, driven by the region's aging population and well-established healthcare systems.

Countries like Germany, France and the UK are key contributors to market growth, with their emphasis on advanced medical imaging technologies and high-quality patient care.

The region's strong focus on research and development in medical imaging is fostering innovations in contrast media formulations and applications.

There is a growing trend towards the use of macrocyclic gadolinium-based contrast agents in Europe due to their improved safety profile.

Global Contrast Media Market: Segmentation Analysis

The Global Contrast Media Market is segmented on the basis of Type, Application, End-User and Geography.

Global Contrast Media Market, by Type

Iodinated Contrast Media

Gadolinium-based Contrast Media

Microbubble Contrast Media

Based on Type, the Global Contrast Media Market is divided into Iodinated Contrast Media, Gadolinium-based Contrast Media and Microbubble Contrast Media segments. The Iodinated Contrast Media segment currently dominates the market due to its widespread use in X-ray and CT imaging procedures, which are among the most common diagnostic imaging modalities. These agents offer excellent visualization of blood vessels and organs. The Gadolinium-based Contrast Media segment is expected to show significant growth during the forecast period, driven by the increasing adoption of MRI procedures and the development of novel, safer gadolinium-based agents.

Global Contrast Media Market, by Application

X-ray/CT

MRI

Ultrasound

Based on Application, the Global Contrast Media Market is categorized into X-ray/CT, MRI and Ultrasound segments. The X-ray/CT segment currently leads the market due to the high volume of X-ray and CT procedures performed globally and the essential role of contrast media in enhancing image quality for these modalities. However, the MRI segment is expected to show rapid growth, driven by the increasing use of MRI for detailed soft tissue imaging and the development of advanced gadolinium-based contrast agents.

Global Contrast Media Market, by End-User

Hospitals

Diagnostic Centers

Ambulatory Surgical Centers

Based on End-User, the Global Contrast Media Market is segmented into Hospitals, Diagnostic Centers and Ambulatory Surgical Centers. The Hospitals segment currently dominates the market due to the high volume of diagnostic imaging procedures performed in hospital settings and the availability of advanced imaging equipment. However, the Diagnostic Centers segment is expected to show the fastest growth during the forecast period, driven by the increasing trend towards outpatient imaging services and the growing number of standalone diagnostic facilities.

Global Contrast Media Market, by Geography

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Based on Geography, the Global Contrast Media Market is divided into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America leads the market, driven by advanced healthcare infrastructure, high healthcare expenditure and early adoption of new imaging technologies. Europe follows closely, with a strong focus on research and development in medical imaging. Asia-Pacific is the fastest-growing region, fueled by improving healthcare access, rising prevalence of chronic diseases and increasing investments in healthcare infrastructure.

Key Players

The Global Contrast Media Market study report will provide valuable insight with an emphasis on the global market. The major players in the Contrast Media Market include

GE Healthcare, Bayer AG, Bracco Imaging S.p.A., Guerbet Group, Lantheus Medical Imaging, Inc., Nano Therapeutics Pvt. Ltd., Nemoto Kyorindo Co., Ltd., Sanochemia Pharmazeutika AG, Taejoon Pharm Co., Ltd. and Unijules Life Sciences Ltd.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above- mentioned players globally.

Contrast Media Market Recent Developments

In April 2024, GE Healthcare launched a new AI-powered contrast media injection system designed to optimize contrast dose and timing for personalized imaging protocols, aiming to improve image quality while reducing the risk of contrast-induced nephropathy.

In August 2024, Bayer AG announced the successful completion of a Phase III clinical trial for a novel gadolinium-based contrast agent with improved relaxivity and safety profile, potentially offering enhanced MRI imaging capabilities for neurological applications.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CONTRAST MEDIA MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CONTRAST MEDIA MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CONTRAST MEDIA MARKET, BY TYPE

• 5.1 Overview
• 5.2 Microbubble Contrast Media
• 5.3 Iodinated Contrast Media
• 5.4 Gadolinium-based Contrast Media
• 5.5 Barium-based Contrast Media

6 GLOBAL CONTRAST MEDIA MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Radiology
• 6.3 Interventional Radiology
• 6.4 Interventional Cardiology

7 GLOBAL CONTRAST MEDIA MARKET, BY MODALITY

• 7.1 Overview
• 7.2 X-ray/Computed Tomography (CT)
• 7.3 Ultrasound
• 7.4 Magnetic Resonance Imaging (MRI)

8 GLOBAL CONTRAST MEDIA MARKET, BY ROUTE OF ADMINISTRATION

• 8.1 Overview
• 8.2 Oral
• 8.3 Intravascular
• 8.4 Rectal
• 8.5 Other Routes

9 GLOBAL CONTRAST MEDIA MARKET, BY INDICATION

• 9.1 Overview
• 9.2 Cardiovascular Disorders
• 9.3 Cancer
• 9.4 Gastrointestinal Disorders
• 9.5 Others

10 GLOBAL CONTRAST MEDIA MARKET, BY GEOGRAPHY

• 10.1 Overview
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 U.K.
  • 10.3.3 France
  • 10.3.4 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Rest of Asia Pacific
• 10.5 Rest of the World
  • 10.5.1 Latin America
  • 10.5.2 Middle East

11 GLOBAL CONTRAST MEDIA MARKET COMPETITIVE LANDSCAPE

• 11.1 Overview
• 11.2 Company Market Ranking
• 11.3 Key Development Strategies

12 COMPANY PROFILES

• 12.1 GE Healthcare
  • 12.1.1 Overview
  • 12.1.2 Financial Performance
  • 12.1.3 Product Outlook
  • 12.1.4 Key Developments
• 12.2 Guerbet LLC
  • 12.2.1 Overview
  • 12.2.2 Financial Performance
  • 12.2.3 Product Outlook
  • 12.2.4 Key Developments
• 12.3 Bayer AG
  • 12.3.1 Overview
  • 12.3.2 Financial Performance
  • 12.3.3 Product Outlook
  • 12.3.4 Key Developments
• 12.4 Bracco Diagnostics Inc.
  • 12.4.1 Overview
  • 12.4.2 Financial Performance
  • 12.4.3 Product Outlook
  • 12.4.4 Key Developments
• 12.5 Lantheus Medical Imaging, Inc.
  • 12.5.1 Overview
  • 12.5.2 Financial Performance
  • 12.5.3 Product Outlook
  • 12.5.4 Key Developments
• 12.6 Daiichi Sankyo Co. Ltd,
  • 12.6.1 Overview
  • 12.6.2 Financial Performance
  • 12.6.3 Product Outlook
  • 12.6.4 Key Developments
• 12.7 Fuji Pharma Co., Ltd
  • 12.7.1 Overview
  • 12.7.2 Financial Performance
  • 12.7.3 Product Outlook
  • 12.7.4 Key Developments

13 Appendix

• 13.1 Related Research